                         SEQUENCE LISTING

<110>  Peptinovo Biopharma, LLC
 
<120>  PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL 
       NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER

<130>  236603-471132

<150>  62/886,282
<151>  2019-08-13

<160>  70    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  V or Aib

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  L or F

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  A or Aib

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  L or F

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  A, L, F or Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  L or F

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  A, Aib or N

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  L or F

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  A, L, F or Aib

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  W, F or L

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  V or Aib

<400>  1

Asp Xaa Xaa Gln Xaa Xaa Lys Glu Xaa Xaa Xaa Gln Xaa Xaa Glu Lys 
1               5                   10                  15      


Xaa Lys Gln Xaa 
            20  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Asp Val Phe Gln Ala Leu Lys Glu Leu Phe Ala Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  3

Asp Val Phe Gln Xaa Leu Lys Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  4
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  4

Asp Val Phe Gln Xaa Leu Lys Glu Leu Leu Ala Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  5
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  5

Asp Val Phe Gln Xaa Leu Lys Glu Leu Leu Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  6
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  6

Asp Val Phe Gln Xaa Leu Lys Glu Leu Leu Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  7
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  7

Asp Val Phe Gln Xaa Leu Lys Glu Leu Leu Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  8
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  8

Asp Val Phe Gln Ala Leu Lys Glu Leu Leu Ala Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  9
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  9

Asp Val Phe Gln Ala Leu Lys Glu Leu Leu Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  10
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  10

Asp Val Phe Gln Xaa Leu Lys Glu Leu Phe Ala Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  11
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  11

Asp Val Phe Gln Xaa Leu Lys Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  12

Asp Val Phe Gln Xaa Leu Lys Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  13
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  13

Asp Val Phe Gln Ala Leu Lys Glu Leu Phe Ala Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  14
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  14

Asp Val Phe Gln Ala Leu Lys Glu Leu Phe Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  15
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  15

Asp Val Phe Gln Ala Leu Lys Glu Leu Phe Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  16
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  16

Asp Val Phe Gln Ala Phe Lys Glu Ala Phe Ala Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  17
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Aib

<400>  17

Asp Val Phe Gln Ala Phe Lys Glu Xaa Phe Ala Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  18
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Aib

<400>  18

Asp Val Phe Gln Xaa Phe Lys Glu Xaa Phe Ala Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  19
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Aib

<400>  19

Asp Val Phe Gln Ala Phe Lys Glu Ala Phe Xaa Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  20
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Aib

<400>  20

Asp Val Phe Gln Ala Phe Lys Glu Xaa Phe Xaa Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  21
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Aib

<400>  21

Asp Val Phe Gln Xaa Phe Lys Glu Xaa Phe Xaa Gln Leu Phe Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  22
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  22

Asp Val Phe Gln Ala Leu Lys Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  23
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Aib

<400>  23

Asp Val Phe Gln Xaa Leu Lys Glu Leu Leu Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Leu Lys Gln Val 
            20  


<210>  24
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D or E

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  V, Y, or Aib

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  L, I, V, W, Y, Aib, Amv, or F

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  L, I, V, W, Y, or F

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  A, G, S, V, Aib, or Amv

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D or E

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  A, G, S L, F, V, Amv, or Aib

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  L, I, V, W, Y, or F

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  L, I, V, W, Y, Aib, Amv, or F

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  A, G, S L, F, V, Amv, or Aib

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  E or D

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  L, I, V, W, Y, or F

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  V, Y, or Aib

<400>  24

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


<210>  25
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<400>  25

Asp Val Phe Gln Lys Leu Xaa Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  26
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  26

Asp Val Phe Gln Lys Leu Val Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  27
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Aib

<400>  27

Asp Val Xaa Gln Lys Leu Phe Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  28
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<400>  28

Asp Val Phe Gln Lys Leu Xaa Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  29
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  29

Asp Val Phe Gln Lys Leu Val Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  30
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Aib

<400>  30

Asp Val Xaa Gln Lys Leu Phe Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Phe Lys Gln Val 
            20  


<210>  31
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Aib

<400>  31

Asp Val Leu Gln Lys Phe Xaa Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  32
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Aib

<400>  32

Asp Val Xaa Gln Lys Phe Leu Glu Leu Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  33
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Aib

<400>  33

Asp Val Phe Gln Lys Leu Leu Glu Xaa Phe Asn Gln Leu Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  34
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Aib

<400>  34

Asp Val Phe Gln Lys Leu Xaa Glu Leu Phe Asn Gln Xaa Leu Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  35
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  35

Asp Val Phe Gln Lys Leu Xaa Glu Leu Phe Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  36
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  36

Asp Xaa Phe Gln Lys Leu Xaa Glu Leu Phe Asn Gln Leu Xaa Glu Lys 
1               5                   10                  15      


Trp Lys Gln Val 
            20  


<210>  37
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  V or Aib

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  W, F, or L

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  A, L, F, or Aib

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  L or F

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  A, Aib or N

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  L or F

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  A, L, F, or Aib

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  L or F

<220>
<221>  misc_feature
<222>  (16)..(16)
<223>  A or Aib

<220>
<221>  misc_feature
<222>  (18)..(18)
<223>  L or F

<220>
<221>  misc_feature
<222>  (19)..(19)
<223>  V or Aib

<400>  37

Xaa Gln Lys Xaa Lys Glu Xaa Xaa Gln Xaa Xaa Xaa Glu Lys Xaa Xaa 
1               5                   10                  15      


Gln Xaa Xaa Asp 
            20  


<210>  38
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  38

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  39
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  39

Val Gln Lys Phe Lys Glu Leu Leu Gln Ala Leu Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  40
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  40

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Leu Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  41
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  41

Val Gln Lys Phe Lys Glu Xaa Leu Gln Asn Leu Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  42
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  42

Val Gln Lys Trp Lys Glu Xaa Leu Gln Asn Leu Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  43
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  43

Val Gln Lys Phe Lys Glu Leu Leu Gln Ala Leu Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  44
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  44

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Leu Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  45
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  45

Val Gln Lys Trp Lys Glu Leu Leu Gln Ala Phe Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  46
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  46

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  47
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  47

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Phe Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  48
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<400>  48

Val Gln Lys Trp Lys Glu Xaa Leu Gln Ala Phe Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  49
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<400>  49

Val Gln Lys Trp Lys Glu Xaa Leu Gln Asn Phe Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  50
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<400>  50

Val Gln Lys Phe Lys Glu Xaa Leu Gln Asn Phe Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  51
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  51

Val Gln Lys Trp Lys Glu Phe Leu Gln Ala Phe Ala Glu Lys Phe Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  52
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Aib

<400>  52

Val Gln Lys Trp Lys Glu Phe Leu Gln Ala Phe Xaa Glu Lys Phe Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  53
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  53

Val Gln Lys Trp Lys Glu Phe Leu Gln Ala Phe Xaa Glu Lys Phe Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  54
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Aib

<400>  54

Val Gln Lys Trp Lys Glu Phe Leu Gln Xaa Phe Ala Glu Lys Phe Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  55
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Aib

<400>  55

Val Gln Lys Trp Lys Glu Phe Leu Gln Xaa Phe Xaa Glu Lys Phe Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  56
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  56

Val Gln Lys Trp Lys Glu Phe Leu Gln Xaa Phe Xaa Glu Lys Phe Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  57
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  57

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Lys Leu Ala 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  58
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Aib

<400>  58

Val Gln Lys Leu Lys Glu Leu Leu Gln Asn Leu Leu Glu Lys Leu Xaa 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  59
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  V, Aib, I, or L

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  W, F, Y, I, V, or L

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  E or D

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  A, G, S, L, F, V, Amv, or Aib

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  L, I, V, W, or F

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  A, G, S, Aib, Amv, V, or N

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  L, I, V, W, or F

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  A, G, S, L, F, V, Amv, or Aib

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  E or D

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  A, G, S, V, Aib, or Amv

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  L, I, V, W, or F

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  K, R, H, or Orn

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Q or N

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  L, I, V, W, or F

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  V, Aib, I, or L

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  E or D

<400>  59

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


<210>  60
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  60

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Xaa Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  61
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  61

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Val Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  62
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Aib

<400>  62

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Phe Leu Lys 
1               5                   10                  15      


Gln Xaa Val Asp 
            20  


<210>  63
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  63

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Phe Leu Glu Xaa Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  64
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  64

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Phe Leu Glu Val Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  65
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Aib

<400>  65

Val Gln Lys Phe Lys Glu Leu Leu Gln Asn Phe Leu Glu Phe Leu Lys 
1               5                   10                  15      


Gln Xaa Val Asp 
            20  


<210>  66
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  66

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Xaa Phe Lys 
1               5                   10                  15      


Gln Leu Val Asp 
            20  


<210>  67
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Aib

<400>  67

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Leu Glu Leu Phe Lys 
1               5                   10                  15      


Gln Xaa Val Asp 
            20  


<210>  68
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Aib

<400>  68

Val Gln Lys Trp Lys Glu Leu Leu Gln Asn Phe Xaa Glu Leu Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  69
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  69

Val Gln Lys Trp Lys Glu Leu Xaa Gln Asn Phe Leu Glu Xaa Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


<210>  70
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Aib

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Aib

<400>  70

Val Gln Lys Trp Lys Glu Xaa Leu Gln Asn Phe Leu Glu Xaa Leu Lys 
1               5                   10                  15      


Gln Phe Val Asp 
            20  


